Labs

Moonshot's Kimi K3
lands at 2.7
trillion parameters, closes
gap with Fable
5 and GPT-5.6
Sol

Beijing-based Moonshot AI released the largest open-weight model ever built on July 16, sending TSMC down 7% and SoftBank down 9% as one independent benchmark ranked K3 ahead of Anthropic's flagship.

Moonshot AI released Kimi K3 on July 16, a 2.7-trillion-parameter open-weight model that Arena.ai’s independent leaderboard now ranks ahead of Anthropic’s Claude Fable 5, previously described as the most capable model widely available. It’s the largest open-weight release on record, and the market read it as exactly what it looks like: the Chinese frontier arriving on schedule.

TSMC fell 7% on Friday despite reporting a 77% jump in quarterly operating profit the same week. SoftBank dropped 9%. Nvidia shed 1.2%. The Hong Kong-listed Chinese rival Z.ai, whose GLM-5.2 was until this week the most-discussed domestic model, plunged nearly 30%. The pattern is legible: a strong earnings print from the most important chip fab in the world couldn’t offset a single weekend of vibe shift around who’s actually leading in models.

The pricing is the second story. K3 lists at $15 per million output tokens, roughly a third of Fable’s $50. GLM-5.2 sits at $4.40 and DeepSeek V4 at $0.87. Chinese labs aren’t competing on the frontier at frontier margins; they’re competing on the frontier at commodity margins, which is a very different structural threat.

That threat is already legible inside American infrastructure. Cursor’s Composer 2 coding agent is built on Kimi K2.5. DoorDash runs K2.6 for what it calls lower-level work. Thinking Machines used K2.5 to generate early post-training data for Inkling. The open weights aren’t a curiosity, they’re a supply chain.

“It’s a genuine capability leap, not a benchmark stunt,” said Simon Koser, chief product officer at the AI startup Tzafon. Patrick Moorhead, CEO of Moor Insights and Strategy, framed the competitive question directly. Alex Liu’s Bank of America analyst team, meanwhile, is the desk investors were reading Friday morning as they marked down the entire Pacific supply chain.

Moonshot itself is priced accordingly. The company raised $2 billion in May at a $20 billion valuation and is now, per the Financial Times, raising again at $31.5 billion. Annual recurring revenue sits above $200 million. The valuation step-up in ten weeks matches the shape of the story: a lab that ships open weights at commodity prices, gets embedded in Western tooling, and forces the American frontier to defend its margins rather than its lead.

The export-control regime was designed to prevent the top of the stack. It has instead reorganized where the top of the stack gets built, and at what price it gets sold. Friday’s tape was the market noticing.

Sources